The Stock Exchange of Hong Kong Limited (The Exchange) adopted new rules on April 30 that for the first time enable pre-revenue companies in “emerging and innovative sectors” — including biotechnology — to submit formal applications to list on that exchange. This was the outcome of a careful four-year process aimed at making the Exchange...